The impact of different anti-vascular endothelial growth factor treatment regimens on reducing burden for caregivers and patients with wet age-related macular degeneration in a single-center real-world Japanese setting-Reference-Cited by-同舟云学术

The impact of different anti-vascular endothelial growth factor treatment regimens on reducing burden for caregivers and patients with wet age-related macular degeneration in a single-center real-world Japanese setting

Published:2017-12-08 Issue:12 Volume:12 Page:e0189035
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Hanemoto Tsukasa^ORCID,Hikichi Yusuke,Kikuchi Norimasa,Kozawa Tadahiko

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference30 articles.

1. Prevalence of visual impairment in the adult Japanese population by cause and severity and future projections;M Yamada;Ophthalmic Epidemiol,2010

2. Nine-year incidence and risk factors for age-related macular degeneration in a defined Japanese population the Hisayama study;M Yasuda;Ophthalmology,2009

3. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis;WL Wong;Lancet Glob Health,2014

4. Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration;JS Heier;Ophthalmology,2012

5. Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six-week results of the VIEW studies;U Schmidt-Erfurth;Ophthalmology,2014

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding Loss to Follow-Up in AMD Patients Receiving VEGF Inhibitor Therapy: Associated Factors and Underlying Reasons;Diagnostics;2024-02-12

2. Older adults’ perceptions of navigating eye healthcare in Denmark. A qualitative study;BJGP Open;2023-10-30

3. Cost-effectiveness analysis of prophylactic laser peripheral iridotomy for primary angle-closure suspect in Japan;Eye;2023-10-28

4. Cost-Effectiveness Analysis of Ranibizumab Biosimilar for Neovascular Age-Related Macular Degeneration in Japan;Ophthalmology and Therapy;2023-05-12

5. DETECT: DEveloping and testing a model to identify preventive vision loss among older paTients in gEneral praCTice – protocol for a complex intervention in Denmark;BMJ Open;2023-05